Literature DB >> 23714277

A combined inspiratory and expiratory muscle training program improves respiratory muscle strength and fatigue in multiple sclerosis.

Andrew D Ray1, Supriya Udhoji, Terry L Mashtare, Nadine M Fisher.   

Abstract

OBJECTIVE: To determine the effects of a short-duration, combined (inspiratory and expiratory), progressive resistance respiratory muscle training (RMT) protocol on respiratory muscle strength, fatigue, health-related quality of life, and functional performance in individuals with mild-to-moderate multiple sclerosis (MS).
DESIGN: Quasi-experimental before-after trial.
SETTING: University rehabilitation research laboratory. PARTICIPANTS: Volunteers with MS (N=21) were divided into 2 groups: RMT (n=11; 9 women, 2 men; mean age ± SD, 50.9 ± 5.7y, mean Expanded Disability Status Scale score ± SD, 3.2 ± 1.9) and a control group that did not train (n=10; 7 women, 3 men; mean age ± SD, 56.2 ± 8.8y, mean Expanded Disability Status Scale score ± SD, 4.4 ± 2.1). Expanded Disability Status Scale scores ranged from 1 to ≤6.5. No patients withdrew from the study. INTERVENTION: Training was a 5-week combined progressive resistance RMT program, 3d/wk, 30 minutes per session. MAIN OUTCOME MEASURES: The primary outcome measures were maximal inspiratory pressure and expiratory pressure and the Modified Fatigue Impact Scale. All subjects completed secondary measures of pulmonary function, the six-minute walk test, the timed stair climb, the Multiple Sclerosis Self-Efficacy Scale, the Medical Outcomes Study 36-Item Short-Form Health Survey, and the Physical Activity Disability Scale.
RESULTS: Maximal inspiratory pressure and expiratory pressure (mean ± SD) increased 35% ± 22% (P<.001) and 26% ± 17% (P<.001), respectively, whereas no changes were noted in the control group (12% ± 23% and -4% ± 17%, respectively). RMT improved fatigue (Modified Fatigue Impact Scale, P<.029), with no change or worsening in the control group. No changes were noted in the six-minute walk test, stair climb, Multiple Sclerosis Self-Efficacy Scale, or Physical Activity Disability Scale in the RMT group. The control group had decreases in emotional well-being and general health (Medical Outcomes Study 36-Item Short-Form Health Survey).
CONCLUSIONS: A short-duration, combined RMT program improved inspiratory and expiratory muscle strength and reduced fatigue in patients with mild to moderate MS.
Copyright © 2013 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6MWT; ATS; American Thoracic Society; Breathing exercises; EDSS; Expanded Disability Status Scale; FEV(1); FVC; Fatigue; HRQOL; MFIS; MS; MSSE; MVV(12); Medical Outcomes Study 36-Item Short-Form Health Survey; Modified Fatigue Impact Scale; Multiple Sclerosis Self-Efficacy Scale; Multiple sclerosis; PFT; Pemax; Pimax; Positive-pressure respiration; RMT; Rehabilitation; SF-36; forced expiratory volume in 1 second; forced vital capacity; health-related quality of life; maximal expiratory pressure; maximal inspiratory pressure; maximal voluntary ventilation in 12 seconds; multiple sclerosis; pulmonary function test; respiratory muscle training; six-minute walk test

Mesh:

Year:  2013        PMID: 23714277     DOI: 10.1016/j.apmr.2013.05.005

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  10 in total

1.  Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study.

Authors:  Tanja Grubić Kezele; Matea Babić; Tamara Kauzlarić-Živković; Tamara Gulić
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

2.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

3. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

Review 4.  Respiratory muscle training for multiple sclerosis.

Authors:  Marc B Rietberg; Janne M Veerbeek; Rik Gosselink; Gert Kwakkel; Erwin Eh van Wegen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-21

5.  Effects of expiratory muscle strength training on maximal respiratory pressure and swallow-related quality of life in individuals with multiple sclerosis.

Authors:  Erin Pearson Silverman; Sarah Miller; Yi Zhang; Bari Hoffman-Ruddy; James Yeager; Janis J Daly
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-05-29

6.  Time to Move Beyond a "One-Size Fits All" Approach to Inspiratory Muscle Training.

Authors:  Ren-Jay Shei; Hunter L Paris; Abigail S Sogard; Timothy D Mickleborough
Journal:  Front Physiol       Date:  2022-01-10       Impact factor: 4.566

Review 7.  Multiple sclerosis-related fatigue lacks a unified definition: A narrative review.

Authors:  Iman Adibi; Mehdi Sanayei; Farinaz Tabibian; Neda Ramezani; Ahmad Pourmohammadi; Kiarash Azimzadeh
Journal:  J Res Med Sci       Date:  2022-03-17       Impact factor: 1.852

Review 8.  Physiological Considerations to Support Podium Performance in Para-Athletes.

Authors:  Cameron M Gee; Melissa A Lacroix; Trent Stellingwerff; Erica H Gavel; Heather M Logan-Sprenger; Christopher R West
Journal:  Front Rehabil Sci       Date:  2021-11-16

9.  The effects of breathing with mainly inspiration or expiration on pulmonary function and chest expansion.

Authors:  Seong-Dae Woo; Tae-Ho Kim; Jin-Yong Lim
Journal:  J Phys Ther Sci       Date:  2016-03-31

10.  Research on the Influence of Anti-fatigue Effect and Movement Ability of Blueberry Polysaccharides on Aged Mice.

Authors:  Bai Bo
Journal:  Open Biomed Eng J       Date:  2015-10-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.